{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:40:39Z","timestamp":1759333239030},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[1997,11,1]],"date-time":"1997-11-01T00:00:00Z","timestamp":878342400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefe's Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[1997,11]]},"DOI":"10.1007\/bf01880673","type":"journal-article","created":{"date-parts":[[2005,7,4]],"date-time":"2005-07-04T20:17:57Z","timestamp":1120508277000},"page":"733-740","source":"Crossref","is-referenced-by-count":10,"title":["Fibroblast growth factor 2, heparin and suramin reduce epithelial ulcer development in experimental HSV-1 keratitis"],"prefix":"10.1007","volume":"235","author":[{"given":"Peter","family":"Rieck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josette","family":"Denis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Pouliquen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Courtois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01880673_CR1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0277-5379(90)90005-E","volume":"26","author":"J-P Armand","year":"1990","unstructured":"Armand J-P, Cvitcovic E (1990) Suramin: a new therapeutic concept. Eur J Cancer 26:417\u2013419","journal-title":"Eur J Cancer"},{"key":"BF01880673_CR2","first-page":"79","volume-title":"Healing processes in the cornea. Advances in applied biotechnology, vol 1","author":"M Assouline","year":"1989","unstructured":"Assouline M, Montefiore G, Pouliquen Y, Courrois Y (1989) Fibroblast growth factor effects on corneal wound healing in rabbit. In: Beuerman RW, Crosson CE, Kaufmann HE (eds) Healing processes in the cornea. Advances in applied biotechnology, vol 1). Gulf, Houston, pp 79\u201397"},{"key":"BF01880673_CR3","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1084\/jem.152.4.931","volume":"152","author":"RG Azizkhan","year":"1980","unstructured":"Azizkhan RG, Azizkhan JC, Zetter BR, Folkman J (1980) Mast cell heparin stimulates migration of capillary endothelial cells in vitro. J Exp Med 152:931\u2013935","journal-title":"J Exp Med"},{"key":"BF01880673_CR4","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0006-291X(87)90292-0","volume":"142","author":"A Baird","year":"1987","unstructured":"Baird A, Ling N (1987) Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: implications for a role of heparinase-like enzymes in the neovascular response. Biochem Biophys Res Commun 142:428\u2013434","journal-title":"Biochem Biophys Res Commun"},{"key":"BF01880673_CR5","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/0006-291X(85)90614-X","volume":"126","author":"A Baird","year":"1985","unstructured":"Baird A, Mormede P, Bohlen P (1985) Immunoreactive fibroblast growth factor in cells of peritoneal exsudate suggests its identity with macrophage-derived growth factor. Biochem Biophys Res Commun 126:358\u2013342","journal-title":"Biochem Biophys Res Commun"},{"key":"BF01880673_CR6","doi-asserted-by":"crossref","first-page":"7773","DOI":"10.1073\/pnas.79.24.7773","volume":"79","author":"MJ Banda","year":"1982","unstructured":"Banda MJ, Knighton DR, Hunt TK, Werb Z (1982) Isolation of a nonmitogenic angiogenic factor from wound fluid. Proc Natl Acad Sci 79:7773\u20137778","journal-title":"Proc Natl Acad Sci"},{"key":"BF01880673_CR7","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1021\/bi00430a047","volume":"28","author":"P Bashkin","year":"1989","unstructured":"Bashkin P, Doctrow S, Klagsbrun M, Svahn CM, Folkman J, Vlodavsky I (1989) Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry 28:1737\u20131743","journal-title":"Biochemistry"},{"key":"BF01880673_CR8","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.1016\/S0021-9258(19)34085-2","volume":"265","author":"A Circolo","year":"1990","unstructured":"Circolo A, Pierce GF, Katz Y, Strunk RC (1990) Antiinflammatory effects of polypeptide growth factors. J Biol Chem 265:5066\u20135071","journal-title":"J Biol Chem"},{"key":"BF01880673_CR9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/jcp.1041320120","volume":"132","author":"RJ Coffey","year":"1987","unstructured":"Coffey RJ, Leof EB, Shipley GD, Moses HL (1987) Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells. J Cell Physiol 132:143\u2013148","journal-title":"J Cell Physiol"},{"key":"BF01880673_CR10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/02713688709020066","volume":"6","author":"J Denis","year":"1987","unstructured":"Denis J, Langlois M, Elkaim M, Amiel C, Aymard M, Huraux (1987) HSV-1 strain sensitivity in experimental rabbit keratitis: evolution under repeated topical IDU administrations. Curr Eye Res 6:39\u201343","journal-title":"Curr Eye Res"},{"key":"BF01880673_CR11","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/0006-291X(85)90942-8","volume":"133","author":"F Esch","year":"1985","unstructured":"Esch F, Ueno N, Baird A (1985) Primary structure of bovine brain acidic FGF. Biochem Biophys Res Commun 133:554\u2013562","journal-title":"Biochem Biophys Res Commun"},{"key":"BF01880673_CR12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/02713689109020372","volume":"10","author":"C Fardeau","year":"1991","unstructured":"Fardeau C, Langlois M, Mathys B (1991) Emergence of cross-resistant herpes simplex virus following topical drug therapy in rabbit keratitis. Curr Eye Res [Suppl] 10:151","journal-title":"Curr Eye Res [Suppl]"},{"key":"BF01880673_CR13","first-page":"393","volume":"130","author":"J Folkman","year":"1988","unstructured":"Folkman J, Klagsbrun M, Sasse J, Wadzinski BA, Ingber D, Vlodavsky (1988) A heparin-binding angiogenic protein \u2014 basic fibroblast growth factor \u2014 is stored within basement membrane. Am J Pathol 130:393\u2013399","journal-title":"Am J Pathol"},{"key":"BF01880673_CR14","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/jcp.1041280317","volume":"128","author":"D Gospodarowicz","year":"1986","unstructured":"Gospodarowicz D, Cheng J (1986) Heparin protects basic and acidic FGF from inactivation. J Cell Physiol 128:475\u2013480","journal-title":"J Cell Physiol"},{"key":"BF01880673_CR15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0014-4835(79)90038-1","volume":"28","author":"D Gospodarowicz","year":"1979","unstructured":"Gospodarowicz D, Bialecki H, Thakral TK (1979) The angiogenic activity of the fibroblast and epidermal growth factor. Exp Eye Res 28:501\u2013505","journal-title":"Exp Eye Res"},{"key":"BF01880673_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0045-6039(86)90021-7","volume":"19","author":"D Gospodarowicz","year":"1986","unstructured":"Gospodarowicz D, Neufeld G, Schweigerer L (1986) Molecular and biological charaterization of FGF, an angiogenic factor which also controls the proliferation and differentiation. Cell Differ 19:1\u201317","journal-title":"Cell Differ"},{"key":"BF01880673_CR17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jcp.1041330405","volume":"5","author":"D Gospodarowicz","year":"1987","unstructured":"Gospodarowicz D, Neufeld G, Schweigerer L (1987) Fibroblast growth factor structural and biological properties. J Cell Physiol 5:15\u201326","journal-title":"J Cell Physiol"},{"key":"BF01880673_CR18","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/0002-9394(88)90838-0","volume":"106","author":"EJ Holland","year":"1988","unstructured":"Holland EJ, Stein CA, Palestine AG (1988) Suramin keratopathy. Am J Ophthalmol 106:216\u2013221","journal-title":"Am J Ophthalmol"},{"key":"BF01880673_CR19","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1021\/bi00122a027","volume":"31","author":"R Ishai-Michaeli","year":"1992","unstructured":"Ishai-Michaeli R, Svahn CM, Weber M (1992) Importance of size and sulfation of heparin in release of basic fibroblast growth factor from the vascular endo thelium and extracellular matrix. Biochemistry 31:2080\u20132088","journal-title":"Biochemistry"},{"issue":"Suppl 1","key":"BF01880673_CR20","first-page":"87","volume":"92","author":"AM Joussen","year":"1995","unstructured":"Joussen AM, Kruse FE, Rohrschneider K, V\u00f6lcker HE (1995) Suramin und Prednisolon bewirken die Hemmung experimenteller kornealer Neovaskularisationen. Ophthalmologe [Suppl 1] 92:87","journal-title":"Ophthalmologe"},{"key":"BF01880673_CR21","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.2162560","volume":"248","author":"RJ Kaner","year":"1990","unstructured":"Kaner RJ, Baird A, Mansukhani A (1990) Fibroblast growth factor is a portal cellular entry for herpes simplex virus type 1. Science 248:1410\u20131412","journal-title":"Science"},{"key":"BF01880673_CR22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0955-2235(89)90012-4","volume":"1","author":"M Klagsbrun","year":"1989","unstructured":"Klagsbrun M (1989) The Fibroblast Growth Factor family: structural and biological properties. Prog Growth Factor Res 1:207\u2013214","journal-title":"Prog Growth Factor Res"},{"key":"BF01880673_CR23","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1073\/pnas.82.3.805","volume":"82","author":"M Klagsbrun","year":"1985","unstructured":"Klagsbrun M, Shing Y (1985) Heparin affinity of anionic and cationic capillary endothelial cell growth factors: analysis of hypothalamus-derived and cationic endothelial growth factors and fibroblast growth factors. Proc Natl Acad Sci 82:805\u2013811","journal-title":"Proc Natl Acad Sci"},{"key":"BF01880673_CR24","first-page":"106","volume":"4","author":"RV LaRocca","year":"1990","unstructured":"LaRocca RV, Stein CA, Meyers CE (1990) Suramin: prototype of a new generation of antitumor compounds. Cancer Cells 4:106\u2013115","journal-title":"Cancer Cells"},{"key":"BF01880673_CR25","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1083\/jcb.107.2.753","volume":"107","author":"D Moscatelli","year":"1988","unstructured":"Moscatelli D (1988) Metabolism of receptor-bound and matrix-bound basic fibroblast growth factor by bovine capillary endothelial cells. J Cell Biol 107:753\u2013759","journal-title":"J Cell Biol"},{"key":"BF01880673_CR26","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/0014-4835(92)90163-M","volume":"54","author":"P Rieck","year":"1992","unstructured":"Rieck P, Assouline M, Savoldelli M, Hartmann C, Jacob C, Pouliquen Y, Courtois Y (1992) Recombinant human basic fibroblast growth factor (rh-FGF-2) in three different wound models in rabbits: corneal wound healing effect and pharmacology. Exp Eye Res 54:987\u2013998","journal-title":"Exp Eye Res"},{"key":"BF01880673_CR27","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1126\/science.1649495","volume":"253","author":"M-T Shieh","year":"1991","unstructured":"Shieh M-T, Spear PG (1991) Fibroblast growth factor receptor: does it have a role in the binding of herpes simplex virus? Science 253:208\u2013209","journal-title":"Science"},{"key":"BF01880673_CR28","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1083\/jcb.116.5.1273","volume":"116","author":"M-T Shieh","year":"1992","unstructured":"Shieh M-T, WuDunn D, Montgomery R, Esko JD, Spear PG (1992) Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J Cell Biol 116:1273\u20131281","journal-title":"J Cell Biol"},{"key":"BF01880673_CR29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0014-4835(82)90053-7","volume":"34","author":"P Thompson","year":"1982","unstructured":"Thompson P, Desbordes JM, Giraud J, Pouliquen Y, Barritault D, Courtois Y (1982) The effect of an eye derived growth factor (EDGF) on corneal epithelial regeneration. Exp Eye Res 34:191\u2013199","journal-title":"Exp Eye Res"},{"key":"BF01880673_CR30","first-page":"7","volume":"171","author":"A Vahery","year":"1964","unstructured":"Vahery A (1964) Heparin and related polyanionic substances as virus inhibitors. Acta Pathol Microbiol Scand Suppl 171:7\u201397","journal-title":"Acta Pathol Microbiol Scand Suppl"},{"key":"BF01880673_CR31","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1073\/pnas.86.9.3199","volume":"86","author":"TC Wright","year":"1989","unstructured":"Wright TC, Pukac LA, Castellot JJ (1989) Heparin suppresses the induction of c-fos and c-myc mRNA in murine fibroblasts by selective inhibition of a proteine kinase C-dependence pathway. Proc Natl Acad Sci 86:3199\u20133203","journal-title":"Proc Natl Acad Sci"},{"key":"BF01880673_CR32","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/JVI.63.1.52-58.1989","volume":"63","author":"D WuDunn","year":"1989","unstructured":"WuDunn D, Spear PG (1989) Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J Virol 63:52\u201359","journal-title":"J Virol"},{"key":"BF01880673_CR33","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0092-8674(91)90512-W","volume":"64","author":"A Yayon","year":"1991","unstructured":"Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM (1991) Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64:841\u2013847","journal-title":"Cell"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01880673.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01880673\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01880673","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:35:54Z","timestamp":1626136554000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01880673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,11]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1997,11]]}},"alternative-id":["BF01880673"],"URL":"https:\/\/doi.org\/10.1007\/bf01880673","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,11]]}}}